22 Mar 2021 14:32
IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
EVG.L Share News (EVG)
EVG Share
Price
EVG Share
News
EVG Share
Chat
EVG Share
Trades
EVG
Live RNS
EVG Share
Charts
EVG Broker
Ratings
EVG Directors
Deals
EVG Financial
Diary
EVG
Fundamentals
EVG Short
Positions
EVG
Media
EVG.L Information
- There is currently no data for EVG
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Wednesday broker round-up
Wed, 25th Jul 2018 13:57
(Sharecast News) - Unite Group: Numis downgrades to hold with a target price of 900p.XLMedia: Berenberg reiterates buy with a target price of 225p.Hastings Group Holdings: Berenberg reiterates buy with a target price of 310p.Countryside properties: Berenberg reiterates buy with a target price of 430p.MJ Gleeson: Berenberg reiterates buy with a target price of 890p.Rio Tinto: RBC Capital Markets downgrades to underperform with a target price of 3,400p.BT Group: RBC Capital Markets downgrades to sector perform with a target price of 275p.Air Partner: Liberum resumes buy with a target price of 155p.Burford Capital: Libertum reiterates buy with a target price of 1,689p.Tyman: Canaccord reiterates buy with a target price of 395p.Marston's: Canaccord reiterates hold with a target price of 110p.Beazley: Peel Hunt reiterates reduce with a target price of 470p.International Personal Finance: Peel Hunt reiterates buy with a target price of 270p.Evgen Pharma: Northland Capital Markets reiterates buy with a target price of 113p.Indivior: Numis upgrades to add with a target price of 380p.Kingfisher: Citigroup upgrades to neutral with a target price of 320p.Boohoo.com: Citigroup downgrades to neutral with a target price of 230p.Medica Group: Berenberg reiterates buy with a target price of 230p.Thomas Cook Group: UBS initiates sell with a target price of 85p.TUI AG: UBS reiterates neutral with a target price of 1,600p.Next: Jefferies reiterates hold with a target price of 6,100p.
More News
22 Mar 2021 09:08
Evgen appoints Helen Kuhlman as chief business officer
(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief business officer, taking up the role from 1 April.
Read more11 Mar 2021 20:08
IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial
IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial
Read more11 Mar 2021 15:12
Evgen Covid-19 trial given all-clear on safety and data
(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Thursday that after a review of the first 60 patients enrolled, the data safety monitoring committee for the 'STAR' Covid-19 trial had concluded that there were no concerns over patient safety or data quality that would prevent its continuation.
Read more3 Mar 2021 20:16
TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up
TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up
Read more24 Feb 2021 16:09
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more17 Feb 2021 15:10
Evgen makes progress with recruitment in 'STAR' trial
(Sharecast News) - Clinical stage drug development company Evgen Pharma said on Wednesday that a total of 102 patients had been recruited and randomised to the 'STAR', or 'SFX-01 Treatment for Acute Respiratory infections', trial.
Read more17 Feb 2021 11:15
IN BRIEF: Evgen Pharma Recruits Over 100 For Respiratory Drug Trial
IN BRIEF: Evgen Pharma Recruits Over 100 For Respiratory Drug Trial
Read more3 Feb 2021 11:49
IN BRIEF: Intuitive Investments Buys Shares in Evgen For GBP175,000
IN BRIEF: Intuitive Investments Buys Shares in Evgen For GBP175,000
Read more2 Feb 2021 17:45
IN BRIEF: Evgen Pharma's GBP11 Fundraise To Support Lead Candidate
IN BRIEF: Evgen Pharma's GBP11 Fundraise To Support Lead Candidate
Read more22 Jan 2021 08:53
Evgen Shares Rise On Further Positive Test Results For SFX-01
Evgen Shares Rise On Further Positive Test Results For SFX-01
Read more21 Jan 2021 13:20
IN BRIEF: Evgen Pharma Notes Positive Preclinical Data For SFX-01
IN BRIEF: Evgen Pharma Notes Positive Preclinical Data For SFX-01
Read more19 Jan 2021 17:34
IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial
IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial
Read more10 Dec 2020 17:07
UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops
UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops
Read more10 Dec 2020 15:45
Evgen Pharma performs in line with forecasts in first half
(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported financial performance in line with its expectations in its first half on Thursday, with revenue coming in at £0.19m, compared to nil a year earlier.
Read more